Ultimovacs AB
Pioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
Overview
- 0
- Employees
- 5–10M SEK
- Revenue
- 2018
- Founded
Key Decision Makers
Namir Hassan
CEO
Description
Zelluna is a biotechnology company dedicated to pioneering novel cell therapies for the treatment of cancer patients. Their core mission is to eliminate solid cancers by developing T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This proprietary platform aims to ove...